1. Home
  2. HOWL vs MSW Comparison

HOWL vs MSW Comparison

Compare HOWL & MSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • MSW
  • Stock Information
  • Founded
  • HOWL 2017
  • MSW 2012
  • Country
  • HOWL United States
  • MSW Hong Kong
  • Employees
  • HOWL N/A
  • MSW N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • MSW
  • Sector
  • HOWL Health Care
  • MSW
  • Exchange
  • HOWL Nasdaq
  • MSW NYSE
  • Market Cap
  • HOWL 87.4M
  • MSW 78.0M
  • IPO Year
  • HOWL 2021
  • MSW 2024
  • Fundamental
  • Price
  • HOWL $1.55
  • MSW $6.42
  • Analyst Decision
  • HOWL Strong Buy
  • MSW
  • Analyst Count
  • HOWL 2
  • MSW 0
  • Target Price
  • HOWL $13.50
  • MSW N/A
  • AVG Volume (30 Days)
  • HOWL 344.3K
  • MSW 165.8K
  • Earning Date
  • HOWL 11-07-2024
  • MSW 02-25-2025
  • Dividend Yield
  • HOWL N/A
  • MSW N/A
  • EPS Growth
  • HOWL N/A
  • MSW N/A
  • EPS
  • HOWL N/A
  • MSW 0.21
  • Revenue
  • HOWL $3,386,000.00
  • MSW $27,572,692.00
  • Revenue This Year
  • HOWL N/A
  • MSW N/A
  • Revenue Next Year
  • HOWL $34.17
  • MSW N/A
  • P/E Ratio
  • HOWL N/A
  • MSW $31.04
  • Revenue Growth
  • HOWL N/A
  • MSW 26.09
  • 52 Week Low
  • HOWL $1.38
  • MSW $3.70
  • 52 Week High
  • HOWL $8.19
  • MSW $8.13
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 36.96
  • MSW N/A
  • Support Level
  • HOWL $1.50
  • MSW N/A
  • Resistance Level
  • HOWL $1.63
  • MSW N/A
  • Average True Range (ATR)
  • HOWL 0.12
  • MSW 0.00
  • MACD
  • HOWL 0.00
  • MSW 0.00
  • Stochastic Oscillator
  • HOWL 30.09
  • MSW 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About MSW MING SHING GROUP HOLDINGS LIMITED

Ming Shing Group Holdings Ltd is a holding company, which is primarily operated through its indirectly wholly-owned Hong Kong Operating Subsidiaries, MS (HK) Engineering Limited and MS Engineering Co., Limited. It is engaged in wet trades works, such as plastering works, tile laying works, brick laying works, floor screeding works and marble works. the company is mainly engaged in private-sector projects in Hong Kong. Its private sector projects mainly involve private residential developments and commercial developments. The project owners of its private sector projects are generally property developers, and its customers are generally main contractors and wet trades work subcontractors engaged under such projects.

Share on Social Networks: